Informed Consent Documents Clause Samples
The Informed Consent Documents clause outlines the requirements and procedures for providing participants with clear, comprehensive information about a study or procedure, ensuring they understand the risks, benefits, and their rights before agreeing to participate. Typically, this clause specifies the content that must be included in consent forms, such as the purpose of the research, potential risks, confidentiality measures, and the voluntary nature of participation. Its core function is to protect participants by ensuring they make knowledgeable decisions, thereby upholding ethical standards and legal compliance in research or medical contexts.
Informed Consent Documents. The Informed Consent Form templates from NTU IRB and NHG DSRB are different. Which Informed Consent Template should I use?
Informed Consent Documents. Sangamo shall provide to Pfizer for Pfizer’s review, comment and approval all forms of draft informed consent documents (including any substantive amendments) for the SB-525 Phase I/II Trial or the SB-525 Phase I/II Long-Term Follow-Up Study prior to submission thereof to any institutional review board or independent ethics committee, to the extent not already submitted prior to the Effective Date. All forms of such informed consent documents provided to Pfizer prior to the Effective Date will be deemed approved by Pfizer. Sangamo shall provide to Pfizer a copy of each informed consent document (including any amendment) that has been approved by an institutional review board or independent ethics committee. Sangamo shall use reasonable efforts to amend the informed consent documents for the SB-525 Phase I/II Trial and the SB-525 Phase I/II Long-Term Follow-Up Study within three (3) months after the Effective Date to allow for Pfizer’s access to data and information as required under this Agreement, to the extent not already provided for therein.